Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2007
06/07/2007US20070128269 Sustained drug release compositions
06/07/2007US20070128268 Pharmaceutical compositions comprising an antibiotic
06/07/2007US20070128266 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders
06/07/2007US20070128265 Regulation of cell proliferation and differentiation using topically applied peptides
06/07/2007US20070128264 Method of cancer screening and method of cancer treatment
06/07/2007US20070128262 Package containing adhesive patch and method of inhibiting drug migration
06/07/2007US20070128261 Method of cancer screening and method of cancer treatment
06/07/2007US20070128253 Encapsulated transfer factor compositions and methods of use
06/07/2007US20070128250 Poly(ester urea) polymers and methods of use
06/07/2007US20070128243 Implantable microbial cellulose materials for various medical applications
06/07/2007US20070128242 Polymeric compositions for controlled release or delivery of pharmacologically active agents
06/07/2007US20070128236 Extraction process
06/07/2007US20070128225 Immunogenic sequences
06/07/2007US20070128212 Ceramidase inhibitor
06/07/2007US20070128206 enhancing antigenicity of a vaccine by administering a sugar cane-derived extract having a low saccharide concentration obtained by column chromatography; ion exchange resin;
06/07/2007US20070128203 Anti-integrin antibodies, compositions, methods and uses
06/07/2007US20070128201 Combined use of ecteinascidin-743 and platinum antineoplastic compounds
06/07/2007US20070128198 Compositions comprising antibodies to human fgl2
06/07/2007US20070128188 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer
06/07/2007US20070128181 Administering within 12 hours after cardiac surgery to patient a blood clotting inhibitor such as a combination of dipyridamole and aspirin, wherein cardiac surgery does not include vein graft coronary artery bypass graft surgery; decreases complications without significant adverse effects; efficiency
06/07/2007US20070128178 Probiotics for gut neuromuscular functions
06/07/2007US20070128176 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
06/07/2007US20070128169 Inhibition of gene expression by delivery of polynucleotides to animal cells in vivo
06/07/2007US20070128167 Complexing agents for compositions containing inclusion complexes
06/07/2007US20070128156 Ophthalmic compositions containing a synergistic combination of two polymers
06/07/2007US20070128155 Cartilage repair methods
06/07/2007US20070128154 Bioabsorbable surgical composition
06/07/2007US20070128153 Biocompatible surgical compositions
06/07/2007US20070128152 Biocompatible tissue sealants and adhesives
06/07/2007US20070128151 Coatings, films; environmentally friendly
06/07/2007US20070128150 3-Maleimidyl-N-(2-{[3-maleimidyl-propionyl]-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-amino}-ethyl)-N-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-propionamide linked to 2 polyoxyethyelne glycol residue and two antibodies or fragments; conjugate; biodegradable
06/07/2007US20070128147 Mixture of zinc particles, fatty amphiphiles and surfactants in aqueous carrier
06/07/2007US20070128138 Gel-Based Cosmetic and Wound-Healing Formulation and Method
06/07/2007US20070128136 Terrein compound having melanin biosynthesis inhibitors and its preparation
06/07/2007US20070128126 Airway Alkalinization as Therapy for Airway Diseases
06/07/2007US20070128125 Pharmaceutical Compositions Based on Tiotropium Salts and Salts of Salmeterol
06/07/2007US20070128123 Stable aqueous solution for aerosol administering
06/07/2007US20070128122 Volatile material-containing compositions having an end of service indicator
06/07/2007US20070128118 Polyglutamate-amino acid conjugates and methods
06/07/2007US20070128116 Multifunctional core for molecular imaging and targeted delivery of macromolecules and drugs
06/07/2007US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
06/07/2007CA2670801A1 Compositions and methods of using sirna to knockdown gene expression and to improve solid organ and cell transplantation
06/07/2007CA2636314A1 Arylmethylene urea derivative and use thereof
06/07/2007CA2632968A1 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
06/07/2007CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2632903A1 Treatment of cancer and other diseases
06/07/2007CA2632794A1 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins
06/07/2007CA2632284A1 3-amino-2-arylpropyl azaindoles and uses thereof
06/07/2007CA2632279A1 Heteroaromatic sulfonamide prodrugs
06/07/2007CA2632272A1 Sulfamoyl sulfonate prodrugs
06/07/2007CA2631931A1 Cancer therapies and pharmaceutical compositions used therein
06/07/2007CA2631826A1 Acid addition salt of dihydropyridine derivative
06/07/2007CA2631822A1 Acid addition salt of optically active dihydropyridine derivative
06/07/2007CA2631775A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/07/2007CA2631760A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders
06/07/2007CA2631757A1 Novel mometasone compositions and methods of making and using the same
06/07/2007CA2631755A1 Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
06/07/2007CA2631750A1 Compositions and methods for inducing neuronal differentiation
06/07/2007CA2631746A1 Urea compounds useful in the treatment of cancer
06/07/2007CA2631741A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/07/2007CA2631693A1 Novel nk1 and nk2 antagonists
06/07/2007CA2631680A1 Compositions containing ansamycin
06/07/2007CA2631652A1 Oxadiazole derivatives with crth2 receptor activity
06/07/2007CA2631646A1 Methods of reducing adverse events associated with pirfenidone therapy
06/07/2007CA2631549A1 Polymorphs of [r-(r*, r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-lh-pyrrole-l-heptanoic acid magnesium salt (2: 1)
06/07/2007CA2631501A1 Confectionary compositions with magnolia bark extract
06/07/2007CA2631343A1 The combination of omega-3 fatty acids and thyroid hormone for treating alzheimer's dementia
06/07/2007CA2631232A1 Novel vinylogous acids derivatives
06/07/2007CA2631221A1 Serotonin transporter (sert) inhibitors
06/07/2007CA2631173A1 Treatment method
06/07/2007CA2631127A1 Biologically active compounds
06/07/2007CA2631123A1 Composition in the form of a spray containing a corticoid and an oil phase
06/07/2007CA2631066A1 Fused heterocyclic compound
06/07/2007CA2630884A1 Inhibitors of c-met and uses thereof
06/07/2007CA2630538A1 Localized delivery of drug combinations
06/07/2007CA2630511A1 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors
06/07/2007CA2630460A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
06/07/2007CA2630438A1 Prodrugs of er.beta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
06/07/2007CA2630410A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
06/07/2007CA2630314A1 1,5-substituted indol-2-yl amide derivatives
06/07/2007CA2630307A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
06/07/2007CA2630270A1 5-substituted indole-2-carboxamide derivatives
06/07/2007CA2630164A1 3-(substituted amino)-pyrazolo[3,4-d]pyrimidines as ephb and vegfr2 kinase inhibitors
06/07/2007CA2629964A1 2-aminobenzamide derivative
06/07/2007CA2629962A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/07/2007CA2629587A1 Prodrug er.beta.-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
06/07/2007CA2629037A1 Compositions comprising a combination of ccr5 and cxcr4 antagonists
06/07/2007CA2628907A1 Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid
06/07/2007CA2627319A1 Purine derivatives and methods of use thereof
06/07/2007CA2624693A1 Pharmaceutical compositions comprising carboxyalkylsulfonic acids
06/07/2007CA2605073A1 Substituted indole compounds having nos inhibitory activity
06/07/2007CA2568825A1 Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases
06/06/2007WO2008088303A1 Pyrimidine-2,4-diamines and their uses
06/06/2007EP1793006A2 Nucleic acid ligands and improved methods for producing the same
06/06/2007EP1792998A2 An unusual retrotransposon from the yeast Candida albicans
06/06/2007EP1792997A1 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
06/06/2007EP1792989A1 13 Transmembrane protein expressed in prostate cancer
06/06/2007EP1792988A2 Compounds and methods for therapy and diagnosis of lung cancer
06/06/2007EP1792985A1 Cell fusion promoter and utilization of the same
1 ... 3723 3724 3725 3726 3727 3728 3729 3730 3731 3732 3733 3734 3735 3736 3737 3738 3739 3740 3741 3742 3743 ... 7860